期刊文献+

急性白血病患者血浆可溶性肿瘤坏死因子受体的测定及其临床意义 被引量:4

CHANGES OF PLASMA SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR(TNFα R)LEVEL AND ITS CLINICAL SIGNIFICANCE IN PATIENTS OF ACUTE LEUKEMIA
下载PDF
导出
摘要 目的 :探讨急性白血病 (AL )患者血浆可溶性肿瘤坏死因子受体 (s TNFα R)变化及其意义。方法 :采用放射免疫沉淀—聚乙二醇分析法测定了 2 7例 AL患者血浆 s TNFα R水平 ,并以 15例正常人作对照。结果 :AL患者血浆 s TNFα R水平显著升高 ,与正常对照组差异有显著性 (P<0 .0 1)。结论 :s TNFα R的异常分泌可能是导致 Objective:To appraise the changes of plasma levels of soluble tumor necrosis factor α receptor (sTNFα R)and its clinical significance in patients of acute leukemia(AL).Methods: Plasmas levels of sTNFα R were detected with radioimmuno precipitation polyethylene glycol assay in 27 AL patients,and 15 normal subjects were used as controls.Results:The plasma levels of sTNFα R in AL patients were obviously increased,showing significantly difference compared with normal controls.Conclusion: The abnormal secretion of sTNFα R maybe one importante factor leading to Al cells grow.
作者 张勇 张一军
出处 《白血病》 2000年第5期274-276,共3页
关键词 急性白血病 肿瘤坏死因子 受体 放射免疫法 Acute leukemia Soluble tumor necrosis factor α receptor Radioimmuno precipitation polyethylene glycol assay
  • 相关文献

参考文献4

二级参考文献2

  • 1侯丽君,中华血液学杂志,1994年,15卷,641页 被引量:1
  • 2Zhou M X,Blood,1991年,77卷,2002页 被引量:1

共引文献22

同被引文献19

  • 1谭齐贤,刘希光.白血病患者血清可溶性白细胞介素2受体测定及意义[J].中华血液学杂志,1993,14(7):377-377. 被引量:1
  • 2黄礼明,胡莉文,陈怡宏,丘和明.青蒿鳖甲汤对急性髓系白血病缓解期免疫功能的影响[J].辽宁中医杂志,2005,32(3):193-194. 被引量:17
  • 3刘小菁.可溶性肿瘤坏死因子受体研究进展[J].国外医学(临床生物化学与检验学分册),1995,16(3):112-114. 被引量:7
  • 4蔡竟惠 周柱.102例造血系统肿瘤患者血清可溶性肿瘤坏死因子受体-Ⅰ测定[J].中华血液学杂志,2000,9(1):28-28. 被引量:1
  • 5Thompson M A,Witzig T E, Kumar S, et al. Plasma levels of tumor necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma. Br J Haematol,2003,123:305-308. 被引量:1
  • 6Salles G, Bienvenu J, Bastion Y, et al. Elevated circu lating levels of TNFa and its p55 solube receptor are associated with an adverse prognosis in lymphoma patients. BrJ Haematol, 1996, 93: 352-359. 被引量:1
  • 7Bark V. Nisman B, Polliack A, et al. The tumor necrosis factor family and correlation with disease activity and response to treatment in hairy cell leukemia. Eur J Haematol ,1999, 62: 71-75. 被引量:1
  • 8Steins M B, Bieker R, Padro T, et al, Thalidomide for the treatment of acute myeloid leukemia. Leuk Lymphoma, 2003, 44: 1489-1493. 被引量:1
  • 9Deng L, Ding W, Granstein R D. Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by langerhans. J Invest Dermatol, 2003, 121:1060-1065. 被引量:1
  • 10Caver TE,Slobod KS,Flynn PM,et al.Profound abnormality of the B/T lymphocyte radio during chemotherapy for pediatric acute lympoblastie leukemia [J].Leukemia,1998,12(4):619. 被引量:1

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部